The Diabetic Foot Syndrome (DFS) is among the most severe complications of diabetes, posing significant risks to patients. Circulatory disorders and nerve damage often lead to small foot injuries going unnoticed. What starts as a minor problem can quickly escalate into chronic wounds, infections, and, in the worst cases, amputations. Each year, hundreds of thousands of people worldwide are affected. In Germany alone, approximately 60,000 amputations are performed annually, of which around 40,000 are due to diabetes.* These alarming figures highlight the need for effective early detection, which could significantly reduce these numbers.
Why are problems often overlooked?
The primary issue lies in the asymptomatic nature of many circulatory disorders. Patients feel no pain and often notice injuries only when it’s too late. Additionally, regular preventive screenings are often lacking. The risk is particularly high because diabetes not only delays wound healing but also reduces the perception of injuries due to neuropathy.
Early detection: The decisive factor
Studies show that timely diagnosis and treatment can significantly reduce the risk of complications associated with diabetic foot syndrome. Approximately one-quarter of all diabetic patients will develop diabetic foot syndrome during the course of their disease.* Regular screenings can help identify critical circulatory disorders at an early stage, dramatically improving treatment outcomes. However, traditional methods are often time-consuming and require specialized personnel, making them challenging to implement in routine practice. Furthermore, their results are frequently affected by high blood pressure and arterial stiffness, which impacts approximately 30% of diabetic patients.
Innovative solutions for vascular diagnostics
This is where the devices from SOT Medical Systems come into play. For the early detection of circulatory disorders commonly associated with diabetic foot syndrome, the AngE™ ABI+ and AngE™ DIABETIC from SOT Medical Systems offer precise and reliable solutions.
With a combination of four pneumatic cuffs and two optical sensors, these devices enable simultaneous measurements at up to six locations – in under three minutes.
The devices provide essential parameters such as the Oscillometric Ankle-Brachial Index (oABI), the Toe-Brachial Index (TBI), and Pulse Wave Velocity (PWV). A standout feature is the Pulse Wave Index (PWI™), which provides a detailed assessment of circulation, unaffected by high blood pressure or arterial stiffness. This is complemented by Tissue Optical Perfusion Pressure (TOPP), a method that delivers precise measurements in the toe and forefoot area, even in patients with medial arterial calcification (MAC) or medial sclerosis.
Thanks to their intuitive software and delegable application, the AngE™ ABI+ and AngE™ DIABETIC seamlessly integrate into daily practice workflows. They support physicians and medical professionals in identifying circulatory disorders early and initiating timely interventions – making them invaluable tools for the prevention and treatment of diabetic foot syndrome.
Prevention saves lives
The objective is clear: prevent complications such as amputations and ensure long-term quality of life for patients. By utilizing innovative technologies, physicians and medical staff can take proactive measures rather than reacting to acute problems after they arise.
Technology as the key to better care
Diabetic foot syndrome is a silent but avoidable risk. Modern screening technologies, such as those provided by SOT Medical Systems, offer physicians and healthcare professionals an effective way to address this issue. With quick, precise, and delegable solutions, prevention becomes both practical and efficient.
Interested in the innovative screening devices from SOT Medical Systems? Contact us for more information and learn how to optimally equip your practice or clinic.
• Source: German Diabetes Society – Press Release, September 28, 2012
